Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Nancy Ann Hosken"'
Autor:
Kening Wang, David M. Koelle, Sally Hunsberger, Siu Ping Turk, Ronald L Hornung, Aiying Chen, Kerry J. Laing, Chetan Seshadri, Lesia K. Dropulic, Sanjay Phogat, Lee-Jah Chang, Malisa T. Smith, Jeffrey I. Cohen, Makinna C Oestreich, Doreen Garabedian, Nancy Ann Hosken, Keith Lumbard, Harlan L Pietz
Publikováno v:
J Infect Dis
Background Herpes simplex virus 2 (HSV2) causes genital herpes in >400 million persons worldwide. Methods We conducted a randomized, double-blinded, placebo-controlled trial of a replication-defective HSV2 vaccine, HSV529. Twenty adults were enrolled
Autor:
Nancy Ann Hosken, Chris L. McClurkan, Changcheng Zhu, David M. Koelle, Manjari Lal, Andrew Roehrig, Eugene Saxon, Dexiang Chen, Darin Zehrung, Courtney Jarrahian
Publikováno v:
Vaccine. 34:2483-2489
Rotavirus infection, which can be prevented by vaccination, is responsible for a high burden of acute gastroenteritis disease in children, especially in low-income countries. An appropriate formulation, packaging, and delivery device for oral rotavir
Autor:
David M. Koelle, Lauren Duncan, Nancy Ann Hosken, Jeremy S. Blum, M. Steven Oberste, Dexiang Chen, John D. Clements, Manjari Lal, Elizabeth B. Norton, Changcheng Zhu, Joshua O. Marshak, Jessica A. White, William C. Weldon
Publikováno v:
Human Vaccines & Immunotherapeutics
Administering vaccines directly to mucosal surfaces can induce both serum and mucosal immune responses. Mucosal responses may prevent establishment of initial infection at the port of entry and subsequent dissemination to other sites. The sublingual
Autor:
Patrick Mcgowan, David M. Koelle, Nancy Ann Hosken, Paul R. Sleath, Felecia Wagener, Amalia Meier, Lawrence Corey, Ken Grabstein, Mark Elliott, Christine M. Posavad
Publikováno v:
Journal of Virology. 80:5509-5515
Cytolytic T cells play a major role in controlling herpes simplex virus type 2 (HSV-2) infections in humans. In an effort to more thoroughly evaluate the response to HSV-2 directly, ex vivo, we developed an enzyme-linked immunospot (ELISPOT) assay th
Autor:
Nancy Ann Hosken
Publikováno v:
Vaccine. 23:2395-2398
A therapeutic vaccine for genital herpes is clearly needed. Vaccines recently developed for HSV-2 in humans have been aimed at eliciting CD4+ T cell responses and neutralizing antibody responses to two HSV-2 glycoproteins (gB and gD). These vaccines
Autor:
Kenneth M. Murphy, Kazuko Shibuya, K Davis, Erin Murphy, Maino, Anne O'Garra, Peter J. M. Openshaw, Nancy Ann Hosken
Publikováno v:
The Journal of Experimental Medicine
Commitment of T helper 1 (Th1) or Th2 populations developing during an immune response to a pathogen, or an inappropriate immune response to an allergen or autoantigen, may determine the difference between health and chronic disease. We show that str
Publikováno v:
Research in Immunology. 146:466-472
Autor:
Christian Pelte, Paul R. Sleath, Bridget L. Mitchell, John B. Edgar, Florian Kern, Andrew W. Sylwester, Jay A. Nelson, Cara Taormina, Kenneth H. Grabstein, Nancy Ann Hosken, Franziska Ruchti, Louis J. Picker
Publikováno v:
The Journal of Experimental Medicine
Human cytomegalovirus (HCMV) infections of immunocompetent hosts are characterized by a dynamic, life-long interaction in which host immune responses, particularly of T cells, restrain viral replication and prevent disease but do not eliminate the vi
Autor:
Anna Wald, Jeffrey Vieira, Christopher L. McClurkan, Zhi Liu, Clement A. Meseda, David M. Koelle, Nancy Ann Hosken, Devon C. Snow, Lawrence Corey, Randal C. Cevallos
The study of immunodominance within microbe-specific CD8 T cell responses has been challenging. We used a previously undescribed approach to create unbiased panels of CD8 cytotoxic T lymphocyte clones specific for herpes simplex virus type 2, a patho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a2b38e93f1bfa8babad91d5d62c0d05
https://europepmc.org/articles/PMC240716/
https://europepmc.org/articles/PMC240716/
Autor:
Xiaoyan Wu, N.-X. Yu, J C Grimaldi, Nancy Ann Hosken, Douglas S. Robinson, R L Coffman, Anne O'Garra, B. W. P. Seymour, G. Grunig, Walter Ferlin, Maureen Howard, Françoise Cottrez, H. Soto
Publikováno v:
Scopus-Elsevier
We have generated rat monoclonal antibodies specific for the mouse eotaxin receptor, C-C chemokine receptor 3 (CCR3). Several anti-CCR3 mAbs proved to be useful for in vivo depletion of CCR3-expressing cells and immunofluorescent staining. In vivo CC